This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,836.78 and is a Firm Fixed Price Delivery Order type, with an ultimate completion date of January 11, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distribution company that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.